Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for Neoplasms
77 locations incl. Birmingham
Sponsor: Celgene
Sex: All·Age: All ages
Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018
Texas Oncology Baylor Charles A. Sammons Cancer Center
Clinical research site in Dallas, Texas · Texas Oncology-Baylor Charles A. Sammons Cancer Center, 3410 Worth St STE 400, Dallas, TX 75246 · (214) 370-1000 · Website
Part of US Oncology
3.6on Google· View on Google Maps
As of September 2026, 23 paid clinical trials are recruiting at Texas Oncology Baylor Charles A. Sammons Cancer Center in Dallas, Texas. Active studies at this site cover conditions such as Breast Cancer and Metastatic Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at Texas Oncology Baylor Charles A. Sammons Cancer Center? We'll email you when one opens.
Recruiting clinical trials at Texas Oncology Baylor Charles A. Sammons Cancer Center (23)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for Breast Cancer
79 locations incl. Phoenix
Sponsor: BriaCell Therapeutics Corporation
Sex: All·Age: 18+
Code: NCT06072612·Phase 3·Recruiting·Listed Oct 2023
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for Small Cell Lung Cancer
26 locations incl. Daphne
Sponsor: Puma Biotechnology, Inc.
Sex: All·Age: 18+
Code: NCT06095505·Phase 2·Recruiting·Listed Oct 2023
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for Breast Cancer
49 locations incl. Mobile
Sponsor: Greenwich LifeSciences, Inc.
Sex: All·Age: 18 - 100
Code: NCT05232916·Phase 3·Recruiting·Listed Feb 2022
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
37 locations incl. Birmingham
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT06901531·Phase 3·Recruiting·Listed Mar 2025
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for Pancreatic Neuroendocrine Tumor (pNET)
40 locations incl. Birmingham
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06943755·Phase 2, Phase 3·Recruiting·Listed Apr 2025
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
for Advanced Cancer
38 locations incl. Birmingham
Sponsor: Artios Pharma Ltd
Sex: All·Age: 18+
Code: NCT04657068·Phase 1, Phase 2·Recruiting·Listed Dec 2020
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for cGVHD
31 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT05919511·Recruiting·Listed Jun 2023
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for AML
36 locations incl. Gilbert
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06001788·Phase 1·Recruiting·Listed Aug 2023
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for Breast Cancer
24 locations incl. Los Angeles
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT05768139·Phase 1, Phase 2·Recruiting·Listed Mar 2023
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for Breast Cancer
113 locations incl. Anchorage
Sponsor: Agendia
Sex: All·Age: 18+
Code: NCT03053193·Recruiting·Listed Feb 2017
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
for Solid Tumors
14 locations incl. Bellflower
Sponsor: Mirati Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT07415031·Phase 2·Recruiting·Listed Feb 2026
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for Non-small Cell Lung Cancer (NSCLC)
19 locations incl. Fountain Valley
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT07288177·Phase 2·Recruiting·Listed Dec 2025
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
for Adult Acute Myeloid Leukemia
13 locations incl. Duarte
Sponsor: Priothera SAS
Sex: All·Age: 18 - 75
Code: NCT05429632·Phase 3·Recruiting·Listed Jun 2022
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
for Advanced Solid Tumor
10 locations incl. Encinitas
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06108050·Phase 1·Recruiting·Listed Oct 2023
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
for B-Cell Non-Hodgkin's Lymphoma (NHL)
2 locations incl. Sacramento
Sponsor: Estrella Biopharma, Inc.
Sex: All·Age: 18+
Code: NCT06343311·Phase 1, Phase 2·Recruiting·Listed Apr 2024
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for Cervical Cancer
117 locations incl. Duarte
Sponsor: GOG Foundation
Sex: Female·Age: 18+
Code: NCT04831580·Recruiting·Listed Apr 2021
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
for Breast Cancer
1 location in Dallas
Sponsor: Baylor Research Institute
Sex: All·Age: 18+
Code: NCT06517212·Phase 2·Recruiting·Listed Jul 2024
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
for Breast Cancer
1 location in Dallas
Sponsor: Baylor Research Institute
Sex: Female·Age: 18+
Code: NCT04265872·EARLY_Phase 1·Recruiting·Listed Feb 2020
Analysis of Graft Function Following Autologous Islet Transplantation
for Chronic Pancreatitis
1 location in Dallas
Sponsor: Baylor Research Institute
Sex: All·Age: 18+
Code: NCT03097185·Recruiting·Listed Mar 2017
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
for Pancreatic Adenocarcinoma
1 location in Dallas
Sponsor: Baylor Research Institute
Sex: All·Age: 18+
Code: NCT04926467·Phase 2·Recruiting·Listed Jun 2021
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
for Metastatic Triple-Negative Breast Carcinoma
1 location in Dallas
Sponsor: Baylor Research Institute
Sex: Female·Age: 18+
Code: NCT06008275·EARLY_Phase 1·Recruiting·Listed Aug 2023
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
for Breast Cancer
12 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT05307705·Phase 1·Recruiting·Listed Apr 2022
Get new-trial alerts for Texas Oncology Baylor Charles A. Sammons Cancer Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Dallas, TX. Unsubscribe anytime.
More research sites in Dallas
- University of Texas Southwestern Medical Center (202 trials)
- UT Southwestern Medical Center (178 trials)
- UT Southwestern/Simmons Cancer Center-Dallas (76 trials)
- University of Texas Southwestern (63 trials)
- Baylor University Medical Center (45 trials)
- Parkland Memorial Hospital (29 trials)
- The University of Texas Southwestern Medical Center (27 trials)
- Medical City Dallas Hospital (24 trials)
- UT Southwestern Simmons Cancer Center - RedBird (24 trials)
- Retina Foundation of the Southwest (22 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.